Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label 1-year safety follow-up of Aricept in children with Down syndrome
2016-004947-35Phase 2
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of donepezil in Down syndrome, sponsored by Eisai Co., Ltd. Primary endpoint: Number of participants with treatment-emergent adverse events and serious adverse events.
02
Drugs
donepezil
03
Conditions
Down syndrome
Beyond the preview
Go deeper on 2016-004947-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004947-35.